Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $20
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
Cantor Fitzgerald Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $21
Avita Medical Price Target Maintained With a $21.00/Share by Cantor Fitzgerald
D. Boral Capital Initiates Avita Medical(RCEL.US) With Buy Rating, Announces Target Price $25
D. Boral Capital Initiates Coverage On AVITA Medical With Buy Rating, Announces Price Target of $25
AVITA Medical Analyst Ratings
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $20
Lake Street Gives a Buy Rating to Avita Medical (RCEL)
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Cuts Target Price to $20
AVITA Medical Analyst Ratings
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
Avita Medical: Strong Buy Rating Backed by Record Sales and Promising Growth Prospects
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
AVITA Medical Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on AVITA Medical, Maintains $21 Price Target
Lake Street Issues a Buy Rating on Avita Medical (RCEL)
BTIG Remains a Hold on Avita Medical (RCEL)